Susquehanna International Group, LLP Xencor Inc Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Xencor Inc stock. As of the latest transaction made, Susquehanna International Group, LLP holds 16,510 shares of XNCR stock, worth $391,452. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,510

Previous 28,698 42.47%

Holding current value

$391,452

Previous $543,000 38.86%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$15.7 - $21.65 $191,351 - $263,870	-12,188 Reduced 42.47%	16,510 $332,000
Q2 2024 Aug 15, 2024	SELL	$18.21 - $24.5 $183,647 - $247,082	-10,085 Reduced 26.0%	28,698 $543,000
Q1 2024 May 07, 2024	BUY	$18.65 - $26.52 $168,838 - $240,085	9,053 Added 30.45%	38,783 $858,000
Q4 2023 Feb 14, 2024	BUY	$16.53 - $21.42 $209,236 - $271,134	12,658 Added 74.14%	29,730 $631,000
Q3 2023 Nov 14, 2023	SELL	$20.08 - $25.39 $284,232 - $359,395	-14,155 Reduced 45.33%	17,072 $344,000
Q2 2023 Aug 11, 2023	SELL	$24.77 - $29.9 $707,579 - $854,123	-28,566 Reduced 47.77%	31,227 $779,000
Q1 2023 May 16, 2023	BUY	$25.95 - $36.95 $794,848 - $1.13 Million	30,630 Added 105.03%	59,793 $1.67 Million
Q4 2022 Feb 14, 2023	SELL	$24.79 - $30.86 $468,754 - $583,531	-18,909 Reduced 39.33%	29,163 $759,000
Q3 2022 Nov 14, 2022	BUY	$24.62 - $32.44 $1.18 Million - $1.56 Million	48,072 New	48,072 $1.25 Million
Q2 2022 Aug 15, 2022	SELL	$19.74 - $29.01 $541,685 - $796,063	-27,441 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$26.68 - $41.63 $665,159 - $1.04 Million	-24,931 Reduced 47.6%	27,441 $732,000
Q4 2021 Feb 14, 2022	BUY	$33.67 - $43.44 $729,729 - $941,475	21,673 Added 70.6%	52,372 $2.1 Million
Q3 2021 Nov 15, 2021	BUY	$30.65 - $35.68 $269,658 - $313,912	8,798 Added 40.17%	30,699 $1 Million
Q2 2021 Aug 11, 2021	SELL	$34.33 - $44.68 $612,000 - $796,510	-17,827 Reduced 44.87%	21,901 $755,000
Q1 2021 May 17, 2021	BUY	$40.81 - $53.88 $451,358 - $595,912	11,060 Added 38.58%	39,728 $1.71 Million
Q4 2020 Feb 16, 2021	BUY	$36.63 - $47.63 $502,929 - $653,959	13,730 Added 91.91%	28,668 $1.25 Million
Q3 2020 Nov 16, 2020	BUY	$30.09 - $43.02 $56,539 - $80,834	1,879 Added 14.39%	14,938 $579,000
Q2 2020 Aug 14, 2020	SELL	$27.76 - $33.42 $280,958 - $338,243	-10,121 Reduced 43.66%	13,059 $423,000
Q1 2020 May 15, 2020	BUY	$20.69 - $37.79 $147,416 - $269,253	7,125 Added 44.38%	23,180 $693,000
Q4 2019 Feb 14, 2020	SELL	$32.75 - $41.43 $281,551 - $356,173	-8,597 Reduced 34.87%	16,055 $552,000
Q3 2019 Nov 14, 2019	SELL	$33.73 - $46.27 $560,491 - $768,868	-16,617 Reduced 40.27%	24,652 $832,000
Q2 2019 Aug 16, 2019	BUY	$29.6 - $40.93 $345,343 - $477,530	11,667 Added 39.41%	41,269 $1.69 Million
Q2 2019 Aug 14, 2019	BUY	$29.6 - $40.93 $876,219 - $1.21 Million	29,602 New	29,602 $1.21 Million
Q1 2018 May 15, 2018	SELL	$21.18 - $33.78 $283,473 - $452,111	-13,384 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$19.29 - $24.83 $258,177 - $332,324	13,384	13,384 $293,000

Others Institutions Holding XNCR

# of Institutions

215

Shares Held

71.5M

Call Options Held

2.5K

Put Options Held

7.9K

View Full List

About Xencor Inc

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.42B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

More about XNCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Xencor Inc Transaction History